U.S. Department of Health & Human Services
Open Funding Opportunities
| FOA # | FOA Title | Research Focus Area | Earliest Submission Date | Expiration Date | Posted Date Sort ascending |
|---|---|---|---|---|---|
| RFA-DA-23-058 | HEAL Initiative: HEAL Data2Action – Acceleration Projects (R33 Clinical Trial Not Allowed) | Cross-Cutting Research | Sat, 10/22/2022 | Wed, 11/23/2022 | Wed, 09/21/2022 |
|
no summary
|
|||||
| RFA-DA-23-057 | HEAL Initiative: HEAL Data2Action – Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional) | Cross-Cutting Research | Sat, 10/22/2022 | Wed, 11/23/2022 | Wed, 09/21/2022 |
|
no summary
|
|||||
| RFA-NR-23-001 | HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) | Clinical Research in Pain Management | Sat, 10/22/2022 | Tue, 11/22/2022 | Fri, 09/16/2022 |
|
no summary
|
|||||
| RFA-NS-23-007 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | Cross-Cutting Research | Sun, 12/04/2022 | Sat, 04/05/2025 | Thu, 09/15/2022 |
|
no summary
|
|||||
| RFA-NS-23-006 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) | Cross-Cutting Research | Sun, 12/04/2022 | Sat, 04/05/2025 | Thu, 09/15/2022 |
|
no summary
|
|||||
| RFA-DA-23-046 | HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) | Mon, 01/02/2023 | Fri, 02/03/2023 | Tue, 09/06/2022 | |
|
no summary
|
|||||
| PAR-22-202 | Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Sat, 09/03/2022 | Tue, 09/02/2025 | Thu, 09/01/2022 |
|
no summary
|
|||||
| PAR-22-200 | Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Sat, 09/03/2022 | Tue, 09/02/2025 | Thu, 09/01/2022 |
|
no summary
|
|||||
| RFA-HD-23-032 | HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Basic Experimental Studies with Humans Required) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 11/07/2022 | Thu, 12/08/2022 | Mon, 08/29/2022 |
|
no summary
|
|||||
| RFA-HD-23-030 | HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 11/07/2022 | Thu, 12/08/2022 | Mon, 08/29/2022 |
|
no summary
|
|||||
| RFA-HD-23-033 | HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 11/07/2022 | Thu, 12/08/2022 | Mon, 08/29/2022 |
|
no summary
|
|||||
| RFA-HD-23-031 | HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Mon, 11/07/2022 | Thu, 12/08/2022 | Mon, 08/29/2022 |
|
no summary
|
|||||
| RFA-EB-22-002 | HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Fri, 10/14/2022 | Wed, 06/18/2025 | Tue, 08/23/2022 |
|
no summary
|
|||||
| NOT-DA-23-005 | Notice of Special Interest (NOSI): HEAL Initiative: Biospecimen Collection in Pregnancy | Enhanced Outcomes for Infants and Children Exposed to Opioids | Sun, 09/25/2022 | Sun, 10/08/2023 | Mon, 08/22/2022 |
|
no summary
|
|||||
| RFA-DA-23-050 | HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Clinical Trial Not Allowed) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Fri, 08/26/2022 | Sat, 02/04/2023 | Thu, 08/18/2022 |
|
no summary
|
|||||
| RFA-DA-23-055 | HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Basic Experimental Studies with Humans Required) | Enhanced Outcomes for Infants and Children Exposed to Opioids | Sat, 01/07/2023 | Wed, 02/08/2023 | Thu, 08/18/2022 |
|
no summary
|
|||||
| RFA-NS-22-070 | HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain (R01 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Tue, 10/04/2022 | Thu, 03/07/2024 | Tue, 08/09/2022 |
|
no summary
|
|||||
| NOT-NS-23-002 | Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech | Preclinical and Translational Research in Pain Management | Tue, 10/18/2022 | Fri, 06/21/2024 | Wed, 08/03/2022 |
|
no summary
|
|||||
| NOT-NS-23-002 | Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech | Preclinical and Translational Research in Pain Management | Tue, 10/18/2022 | Fri, 06/21/2024 | Wed, 08/03/2022 |
|
no summary
|
|||||
| NOT-DA-23-008 | Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes | Cross-Cutting Research | Wed, 10/05/2022 | Mon, 09/08/2025 | Wed, 08/03/2022 |
|
no summary
|
|||||
| NOT-DA-23-007 | Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence | Translation of Research to Practice for the Treatment of Opioid Addiction | Wed, 10/12/2022 | Sun, 07/13/2025 | Wed, 08/03/2022 |
|
no summary
|
|||||
| RFA-DE-23-015 | HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed) | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Fri, 12/16/2022 | Wed, 02/15/2023 | Wed, 08/03/2022 |
|
no summary
|
|||||
| RFA-DE-23-016 | HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed) | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Fri, 12/16/2022 | Wed, 02/15/2023 | Wed, 08/03/2022 |
|
no summary
|
|||||
| RFA-DA-23-054 | HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) | Cross-Cutting Research | Fri, 10/14/2022 | Thu, 03/21/2024 | Wed, 08/03/2022 |
|
no summary
|
|||||
| RFA-DA-23-053 | HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) | Translation of Research to Practice for the Treatment of Opioid Addiction | Fri, 10/14/2022 | Thu, 03/21/2024 | Wed, 08/03/2022 |
|
no summary
|
|||||
| RFA-NS-23-003 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Sat, 09/10/2022 | Tue, 06/10/2025 | Mon, 08/01/2022 |
|
no summary
|
|||||
| NOT-NS-23-009 | Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Fri, 11/11/2022 | Sat, 07/01/2023 | Fri, 07/29/2022 |
|
no summary
|
|||||
| RFA-DA-23-048 | HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required) | New Strategies to Prevent and Treat Opioid Addiction | Sat, 10/08/2022 | Wed, 11/09/2022 | Tue, 07/26/2022 |
|
no summary
|
|||||
| RFA-NS-22-065 | HEAL Initiative: Coordinated Pain Care in Health Care Systems Research Program - Coordinating Center (U24 Clinical Trial Not Allowed) | Clinical Research in Pain Management | Tue, 10/04/2022 | Sat, 11/05/2022 | Thu, 07/21/2022 |
|
no summary
|
|||||
| RFA-NS-22-053 | NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional) | Clinical Research in Pain Management | Tue, 10/04/2022 | Sat, 11/05/2022 | Thu, 07/21/2022 |
|
no summary
|
|||||
| NOT-DA-23-011 | Notice of Special Interest (NOSI): HEAL Initiative: Regarding the Availability of Administrative Supplements to Support the Addition of Justice Measures | Translation of Research to Practice for the Treatment of Opioid Addiction | Mon, 08/01/2022 | Tue, 05/16/2023 | Thu, 07/14/2022 |
|
no summary
|
|||||
| PAS-22-206 | HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) | Cross-Cutting Research | Mon, 09/12/2022 | Thu, 11/13/2025 | Thu, 07/14/2022 |
|
no summary
|
|||||
| NOT-NS-22-095 | HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery | Clinical Research in Pain Management | Tue, 10/18/2022 | Wed, 06/25/2025 | Thu, 07/14/2022 |
|
no summary
|
|||||
| PAS-22-207 | HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) | Cross-Cutting Research | Mon, 09/12/2022 | Thu, 11/13/2025 | Thu, 07/14/2022 |
|
no summary
|
|||||
| RFA-AT-23-002 | HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) | Clinical Research in Pain Management | Fri, 10/21/2022 | Sat, 10/22/2022 | Wed, 07/13/2022 |
|
no summary
|
|||||
| RFA-DA-23-051 | HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) | New Strategies to Prevent and Treat Opioid Addiction | Mon, 01/02/2023 | Thu, 02/02/2023 | Wed, 07/13/2022 |
|
no summary
|
|||||
| RFA-AT-23-001 | HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) | Clinical Research in Pain Management | Fri, 10/21/2022 | Sun, 11/13/2022 | Wed, 07/13/2022 |
|
no summary
|
|||||
| RFA-DA-23-041 | HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required) | Clinical Research in Pain Management | Sat, 08/27/2022 | Wed, 09/28/2022 | Mon, 07/11/2022 |
|
no summary
|
|||||
| RFA-DA-23-042 | HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional) | Clinical Research in Pain Management | Sat, 08/27/2022 | Wed, 09/28/2022 | Mon, 07/11/2022 |
|
no summary
|
|||||
| RFA-DA-23-046 | HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) | Translation of Research to Practice for the Treatment of Opioid Addiction | Mon, 01/02/2023 | Fri, 02/03/2023 | Wed, 07/06/2022 |
|
no summary
|
|||||
| NOT-NS-22-087 | Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain | Clinical Research in Pain Management | Mon, 06/20/2022 | Fri, 02/16/2024 | Mon, 06/06/2022 |
|
no summary
|
|||||
| OTA-20-008 | HEAL Initiative: EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) [ROLLING SUBMISSION ACCEPTED: THIS CLOSED DATE WILL BE ON THE EPPIC NET WEBPAGE] | Clinical Research in Pain Management | Fri, 06/03/2022 | Wed, 07/31/2030 | Fri, 06/03/2022 |
|
no summary
|
|||||
| OTA-20-002 | HEAL Initiative: EPPIC-Net Pain Research Asset Application – Dossier (OT1) [ROLLING SUBMISSION ACCEPTED: THIS CLOSED DATE WILL BE ON THE EPPIC NET WEBPAGE] | Clinical Research in Pain Management | Fri, 06/03/2022 | Wed, 07/31/2030 | Fri, 06/03/2022 |
|
no summary
|
|||||
| RFA-NS-22-052 | HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Mon, 05/09/2022 | Wed, 10/11/2023 | Fri, 04/22/2022 |
|
no summary
|
|||||
| NOT-NS-22-049 | Notice of Early Termination of RFA-NS-21-015 "HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed)" | Preclinical and Translational Research in Pain Management | Sat, 03/27/2021 | Wed, 10/11/2023 | Fri, 04/22/2022 |
|
no summary
|
|||||
| NOT-DA-22-056 | Notice of Special Interest (NOSI): Developing Digital Therapeutics for Substance Use Disorders | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Wed, 04/06/2022 | Thu, 12/07/2023 | Fri, 02/18/2022 |
|
no summary
|
|||||
| RFA-NS-22-050 | HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) | Preclinical and Translational Research in Pain Management | Fri, 02/11/2022 | Fri, 02/24/2023 | Tue, 02/08/2022 |
|
no summary
|
|||||
| NOT-DA-22-001 | Notice of Change to Key Dates for NIDA PAR-21-183, Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Sun, 07/04/2021 | Thu, 12/07/2023 | Sun, 02/06/2022 |
|
no summary
|
|||||
| RFA-NS-22-018 | HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Thu, 02/17/2022 | Fri, 03/10/2023 | Fri, 02/04/2022 |
|
no summary
|
|||||
| RFA-NS-22-021 | HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Thu, 02/17/2022 | Wed, 10/12/2022 | Tue, 02/01/2022 |
|
no summary
|
|||||
| PAR-22-058 | Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) | Preclinical and Translational Research in Pain Management, Cross-Cutting Research | Tue, 02/15/2022 | Tue, 05/02/2023 | Fri, 01/21/2022 |
|
no summary
|
|||||
| PAR-22-058 | Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) | Preclinical and Translational Research in Pain Management, Cross-Cutting Research | Tue, 02/15/2022 | Tue, 05/02/2023 | Fri, 01/21/2022 |
|
no summary
|
|||||
| NOT-TR-22-015 | Notice of Early Termination of PAR-22-057 "Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)" | Cross-Cutting Research | Tue, 02/15/2022 | Tue, 05/02/2023 | Thu, 01/20/2022 |
|
no summary
|
|||||
| RFA-TR-22-011 | Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Fri, 01/28/2022 | Tue, 05/23/2023 | Thu, 01/20/2022 |
|
no summary
|
|||||
| RFA-TR-22-013 | Emergency Awards: HEAL Initiative – New Innovator Award (DP2 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Fri, 01/28/2022 | Tue, 05/23/2023 | Thu, 01/20/2022 |
|
no summary
|
|||||
| RFA-NS-22-034 | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Wed, 02/02/2022 | Sat, 12/07/2024 | Fri, 01/07/2022 |
|
no summary
|
|||||
| RFA-NS-21-029 | HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sat, 06/19/2021 | Wed, 10/11/2023 | Tue, 06/08/2021 |
|
no summary
|
|||||
| NOT-NS-21-061 | Notice of Early Termination of RFA-NS-21-016, HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sat, 06/19/2021 | Wed, 10/11/2023 | Tue, 05/18/2021 |
|
no summary
|
|||||
| PAR-21-183 | Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Sun, 07/04/2021 | Thu, 12/07/2023 | Tue, 03/23/2021 |
|
no summary
|
|||||
| OTA-21-005 | HEAL Initiative: EPPIC-Net Pain Research Asset Application (OT1) | Clinical Research in Pain Management | Fri, 12/17/2021 | Tue, 09/03/2024 | Thu, 02/25/2021 |
|
no summary
|
|||||
| NOT-NS-20-107 Show Summary |
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | Cross-Cutting Research | Sun, 11/15/2020 | Thu, 05/16/2024 | Mon, 10/19/2020 |
|
Diversity Supplement Guidance pdf 221.15 KB |
|||||